Ligand Pharmaceuticals, Inc. (LGND)
213.21
-5.77
(-2.63%)
USD |
NASDAQ |
May 15, 16:00
212.00
-1.21
(-0.57%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 4.273B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 523.59M |
| Johnson & Johnson | 545.74B |
| Organon & Co. | 3.519B |
| Merck & Co., Inc. | 275.09B |
| Phathom Pharmaceuticals, Inc. | 946.70M |
Market Cap Related Metrics
| PE Ratio | 28.91 |
| PS Ratio | 15.84 |
| Price to Book Value | 4.284 |
| Price to Free Cash Flow | 38.12 |
| Price | 213.21 |
| Earnings Yield | 3.46% |
| Operating PE Ratio | 42.96 |
| Normalized PE Ratio | 33.87 |